- Issuer ticker
-
CHE
- Reported as of
-
20 Oct 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
22 Oct 2026, 13:34:10 UTC
Filing notes and source
Key filing fact
Joel L. Wherley filed Form 4 for CHEMED CORP (CHE) on 22 Oct 2026.
Key facts
- This page summarizes Joel L. Wherley's Form 4 filing for CHEMED CORP (CHE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 22 Oct 2026, 13:34.
Change
- Previous filing in this sequence was filed on 06 Aug 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002083070
Primary reporting owner
Wherley Joel L
- Relationship
-
CEO - Vitas Healthcare
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CHE
transaction
Derivative
Stock Option (right to buy with tandem tax withholding)
Award
- Transaction value
- Shares
- +12,686
- Change %
- +42%
- Price
-
$512.64*
- Shares after
- 42,906
- Date
- 20 Oct 2026
- Ownership
- Direct
- Underlying class
- Capital Stock
- Underlying amount
- 12,686
- Exercise price
- $512.64
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote